This startup develops an AI-driven diagnostic platform that utilizes proprietary vision test strips and image recognition software to enhance health testing accuracy in workplace environments. By integrating seamlessly with existing point-of-care systems, it enables rapid and reliable health assessments, improving employee health management and operational efficiency.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional point-of-care (POC) drug and alcohol testing processes often involve manual data entry, increasing the risk of human error and slowing down decision-making. Existing systems may also lack seamless integration with third-party software and comprehensive data security measures, leading to inefficiencies and potential compliance issues.
Solution
Neopharma Technologies offers NEOVAULT, an AI-powered, device-agnostic platform that digitizes and secures drug, alcohol, and impairment test data at the point of care. The NEOVAULT system uses a mobile app with AI vision technology to accurately read, record, and report test results from any NEOVAULT-enabled testing device, eliminating manual data entry and minimizing errors. The platform securely stores and manages test data in a centralized, cloud-based database, providing instant access to real-time information and customizable reporting. NEOVAULT is designed for flexible configuration and seamless API integration with third-party platforms, ensuring top-tier data security and regulatory compliance with ISO 27001, HIPAA, GDPR, and SOC2 Type 2 certifications.
Target Audience
The primary target audience includes employers, third-party administrators (TPAs), distributors, and manufacturers involved in workplace drug and alcohol testing, as well as healthcare providers seeking to improve the accuracy and efficiency of POC testing programs.
Features
- AI-enhanced reader accurately captures and processes POC drug and alcohol test results from various testing devices.
- Mobile app streamlines donor verification and test documentation through an integrated chain of custody workflow.
- Cloud-based software platform offers flexible configurations, customizable reporting, and seamless API integration.
- Integrates rapid drug testing with cognitive impairment technology for efficient and objective impairment measurement.
- Compatible with any NEOVAULT-enabled drug or alcohol testing device, offering flexibility in testing options.
- Provides a secure, paperless workflow that reduces costs and enhances the donor experience.
- Supports emerging trends in workplace monitoring, including continuous monitoring and THC impairment assessment.
- Certified to ISO 27001, HIPAA, GDPR, and SOC2 Type 2 standards for top-tier data security and regulatory compliance.